Progenics Pharmaceuticals Inc (NASDAQ:PGNX)

4.64
Delayed Data
As of Jan 24
 -0.06 / -1.28%
Today’s Change
3.42
Today|||52-Week Range
6.37
-8.84%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Operating ActivitiesNet Income / Starting Line-39.1M10.7M-51.0M-67.7M
 
 
 
 
 
Depreciation565.0K2.1M1.1M1.5M
 
 
 
 
 
Total Other Cash Flow4.5M-1.6M7.0M22.9M
 
 
 
 
 
Funds From Operations-34.1M13.0M-54.3M-44.8M
 
 
 
 
 
Funds From/For Other Operating Expenses6.0M-6.2M-713.0K2.0M
 
 
 
 
 
Net Cash Flow - Operating Activities-40.1M19.2M-53.6M-46.8M
 
 
 
 
 
 
InvestingCapital Expenditures-370.0K-4.3M-269.0K-817.0K
 
 
 
 
 
Fixed Asset Disposal48.0K347.0K52.0K0.00
 
 
 
 
Net Assets From Acquisitions -6.5M-368.0K0.000.00
 
 
 
Net Cash Flow Investing-6.8M-4.3M-217.0K-817.0K
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings0.0048.7M0.000.00
 
 
Long Term Debt Reduction0.000.000.00-5.4M
 
 
Net Proceeds Stock Sale1.7M1.3M5.5M100.1M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing1.7M50.0M5.5M94.7M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash17.0K-86.0K83.0K-92.0K
 
 
 
 
 
 
Net Change In Cash-45.2M64.9M-48.4M47.1M